M42 Health
Riyad Abbasakoor, FCA, is a seasoned financial leader with extensive experience spanning over two decades in commercial finance, strategic leadership, and technology-driven business solutions. Currently serving as Commercial Finance Director at M42 Health since September 2021, Riyad plays a pivotal role in launching innovative products and services while managing multi-million dollar commercial transactions. As the Founder and CFO of QuantumX, a technology start-up focused on digital transformation in the MENA region, Riyad integrates advanced technologies such as RPA and blockchain to enhance operational efficiencies. Previous significant roles include Chief Financial Officer at DEX, Finance Director at Etisalat overseeing a substantial asset base, and leadership positions at British Telecommunications and PricewaterhouseCoopers. Riyad's education includes a Fellowship from the Institute of Chartered Accountants in England and Wales, a BSc from The London School of Economics, and ongoing studies in CXO Leadership at Cornell Johnson Graduate School of Management.
This person is not in any teams
This person is not in any offices
M42 Health
14 followers
M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement. The company is seeking to transform lives through innovative clinical solutions that can solve the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is transforming the traditional healthcare ecosystem and delivering the highest level of precise, patient-centric, and preventative care. M42 has over 20,000 employees and more than 450 facilities in 26 countries around the world. M42 owns a wide portfolio of assets that includes Amana Healthcare, Biogenix Labs, Danat Al Emarat, Diaverum, HealthPoint Hospital, the HealthPlus network of specialty centers, Moorfields Eye Hospital Abu Dhabi, Imperial College London Diabetes Centre, Insights Research Organization & Solutions (IROS), Omics Center of Excellence and National Reference Laboratory, among others.